JMJulia Mądrzak

Julia Mądrzak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julia Mądrzak has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Impact of Regular Cycling on Cardiovascular Health: A Review of Current Evidence

    by Marcelina Skajewska, Julia Stojko, Magdalena Iwaszko, Wojciech ZięBka, Oliwia DziewięCka, Julia Mądrzak, Wojciech Kwieciński, Damian Szymański

    Introduction. Cycling is an accessible form of aerobic physical activity that can be used for recreation, active transport, prevention, and rehabilitation. Aim. To evaluate the relationship between regular cycling and cardiovascular risk factors, vascular function, cardiovascular disease (CVD), and mortality. Methods. A structured narrative review of studies published from 2017 to August 2026 was conducted using PubMed/MEDLINE, supplemented by publisher records and reference lists. Cohort studies, randomized trials, systematic reviews, and meta-analyses were considered. Results. Cycling was associated with lower CVD incidence and cardiovascular mortality in large observational cohorts and meta-analyses. Evidence also supports favorable effects of aerobic exercise on endothelial function, arterial stiffness, blood pressure, cardiorespiratory fitness, and cardiometabolic risk factors. Cycle ergometry is a useful modality in structured cardiac rehabilitation. Conclusions. Regular cycling is associated with favorable cardiovascular outcomes and can contribute to prevention, active-transport strategies, and supervised rehabilitation.

  • Open Access

    Post-Exercise Elevations in Organ Injury-Associated Biomarkers: Kinetics, Confounders, and Clinical Red Flags - A Narrative Review

    by Wojciech ZięBka, Oliwia DziewięCka, Julia Mądrzak, Bartłomiej Markowski, Magdalena Iwaszko, Julia Stojko, Marcelina Skajewska, Wojciech Kwieciński, Julia Kaczmarek, Dominik Zając

    Background: Strenuous exercise can simultaneously alter muscle-, cardiac-, kidney-, liver-associated, inflammatory and haematological biomarkers. Values above population reference intervals may reflect exercise-related kinetics, concentration changes or pathology. Aim: To synthesise post-exercise biomarker kinetics, major modifiers, preanalytical confounders and features distinguishing a transient response from findings requiring further evaluation. Material and methods: This narrative review searched PubMed and Scopus for English-language publications from January 2008 to June 2026; Google Scholar and reference lists provided supplementary coverage. Evidence was appraised qualitatively and synthesised narratively without meta-analysis. Results: CK, myoglobin, cardiac troponin, creatinine, urinary kidney biomarkers, AST, ALT, LDH and haemolysis-associated measures followed marker- and protocol-specific trajectories. Interpretation depended on exercise modality, dose and novelty, sampling time, hydration and plasma-volume shifts, baseline values, assay characteristics and serial direction. No isolated result reliably localised structural injury or provided a universal threshold or normalisation time. Symptoms, associated findings, persistence, worsening or patterns discordant with the exposure support urgent or targeted evaluation. Conclusions: Exact sampling time and serial trajectory are more informative than isolated reference-interval crossing. Clinical and multibiomarker context is essential; short-term normalisation may support an exercise-related explanation but does not prove benignity or exclude transient structural change. The proposed checklist is conceptual and unvalidated. Standardised longitudinal studies are needed.

  • Open Access

    Cold Water Immersion as a Supporting Method for Post-Exercise Recovery and a Potential Tool for Improving General Health – A Narrative Review

    by Bartłomiej Markowski, Martyna Grzywacz, Agnieszka Dobrowolska, Marta Rząsa, Wojciech ZięBka, Oliwia DziewięCka, Wojciech Kwieciński, Julia Mądrzak, Magdalena Iwaszko, Agata Kaczmarzyk

    Background. Cold Water Immersion (CWI) is a widely used recovery strategy in sports; however, its effectiveness depends on the type of exercise performed and the intended training goals. This narrative review evaluated the effects of CWI on post-exercise recovery, neuromuscular function, training adaptations, and general health. Materials and methods. A systematic search of PubMed, Scopus, and Web of Science databases was conducted to identify experimental studies, randomized controlled trials, systematic reviews, and meta-analyses investigating the effects of CWI. The available evidence was narratively reviewed and qualitatively synthesized. Results. CWI reduces delayed onset muscle soreness (DOMS), improves perceived recovery, and may accelerate neuromuscular recovery following high-intensity exercise. However, regular CWI application after resistance training may attenuate hypertrophic adaptations. Evidence regarding the general health benefits of CWI remains limited. Conclusions. CWI represents an effective short-term recovery strategy; however, its application should be tailored to individual training objectives. Further research is required to establish optimal protocols and determine long-term physiological effects.

  • Open Access

    Digital Eye Strain in Esports Athletes: Blink Suppression, Ocular-Surface Symptoms, and Binocular Vision Findings - A Narrative Review

    by Oliwia DziewięCka, Wojciech ZięBka, Julia Mądrzak, Bartłomiej Markowski, Magdalena Iwaszko, Julia Stojko, Marcelina Skajewska, Wojciech Kwieciński, Julia Kaczmarek, Julia Kujawa, et al.

    Background. Competitive esports requires prolonged near-screen viewing and sustained visual attention, making digital eye strain (DES) clinically relevant to players. Aim. To synthesize direct evidence from esports and gaming-task studies with clearly labeled indirect evidence on symptoms, blinking, the ocular surface, accommodation, vergence, risk modifiers, clinical assessment, and management. Material and methods. This focused narrative review integrated publications from 2015 through 1 July 2026, including direct esports and gaming-task studies and clearly identified indirect evidence from other screen-user populations. Interpretation considered study design, population, outcomes, directness, and limitations. Results. Direct esports and gaming-task studies support acute worsening of symptoms, task-related blink suppression, and selected short-term or cross-sectional differences in near-vision measures. Evidence of chronic ocular disease, irreversible injury, or effects on competitive performance remains insufficient. Symptoms, objective ocular signs, and dry eye disease are distinct outcomes. Conclusions. Assessment should be symptom-led and should address ocular-surface, refractive, binocular, and ergonomic contributors. Breaks and ergonomic adjustments are reasonable low-risk measures, but blue-light-filtering lenses and the exact 20-20-20 schedule should not be presented as proven treatments.

  • Open Access

    APPLICATION OF AUTOLOGOUS PLATELET CONCENTRATES (PRP/PRF) IN ACNE SCAR REDUCTION AND THEIR ROLE IN IMPROVING PATIENTS’ PSYCHOSOCIAL QUALITY OF LIFE: A LITERATURE REVIEW

    by Julia Mądrzak, Mikołaj Magierski, Maciej Magierski, Weronika Dudek, Marcelina Skajewska, Julia Stojko, Oliwia DziewięCka, Wojciech ZięBka, Bartłomiej Markowski

    Background: Atrophic acne scars represent a prevalent dermatological challenge with significant cosmetic and psychosocial implications. While autologous platelet concentrates (APCs), such as platelet-rich plasma (PRP), are widely used to promote tissue repair, single-modality approaches often yield sub-optimal structural reconstruction in deep scarring. Objective: This review evaluates the biophysical mechanisms, release kinetics, and clinical efficacy of autologous platelet concentrates – specifically comparing classical PRP with advanced liquid platelet-rich fibrin (f-PRF/i-PRF) – both as monotherapy and within hybrid protocols combined with microneedling, subcision, and ablative fractional CO2 laser resurfacing. Methods: A comprehensive synthesis of current preclinical and clinical literature was conducted, analyzing the impact of centrifugation physics (relative centrifugal force, rotor geometry, chemical additives) on cellular viability and the structural remodeling cascade. Results: Liquid PRF modalities, prepared without exogenous anticoagulants, demonstrate superior biological kinetics compared to PRP, forming a three-dimensional bio-scaffold that enables sustained growth factor release (up to 10–14 days) and homogenous leukocyte migration. Clinical data unequivocally indicate that hybrid procedures outperform monotherapies. Synergizing physical interventions such as microneedling, CO2 laser resurfacing, or subcision with autologous cytokines markedly enhances neocollagenesis and extracellular matrix remodeling. Furthermore, combining APCs with physical modalities significantly reduces post-procedural erythema, edema, downtime, and the incidence of post-inflammatory hyperpigmentation. Conclusion: Advanced platelet-rich fibrin matrices represent a therapeutic evolution over traditional PRP, particularly in preventing fibrous re-anchoring during subcision and providing extended paracrine signaling. Establishing standardized centrifugation protocols and objective evaluation metrics remains essential to fully optimize APC-driven regenerative therapy in dermatological surgery.

  • Open Access

    Nutrigenomics and epigenetics in type 2 diabetes mellitus (T2DM) prevention – literature review

    by Natalia Kosińska, Maria Lucyna Lamorska, Piotr Adam Gebuza, Klaudia Jurkowska, Agata Ostrowska, Weronika Dudek, Julia Mądrzak, Monika Kulińska, Izabela Kołdej, Dominika Dutkiewicz

    Introduction and objective: Type 2 diabetes mellitus affects more than 500 million adults worldwide and continues to increase. Diet shapes molecular pathways regulating insulin sensitivity, inflammation and glucose metabolism. Nutrigenomics studies nutrient-gene interactions,...

  • Open Access

    Mechanistic actions of Bisphenol A and its analogues as thyroid-disrupting chemicals

    by Julia Delfina Latocha, Izabela Kołdej, Piotr Adam Gebuza, Agata Ostrowska, Maria Lucyna Lamorska, Julia Mądrzak, Monika Kulińska, Weronika Dudek, Klaudia Jurkowska

  • Open Access

    OVERTRAINING SYNDROME AND MENTAL HEALTH IN ATHLETES - A LITERATURE REVIEW

    by Dominika Dutkiewicz, Klaudia Jurkowska, Julia Mądrzak, Olga Endler, Mikołaj Dybicz, Marianna Ciastoń, Magdalena Filuk, Jakub Fidelus, Julia Czerniewska, Marta Handzel

    Overtraining Syndrome (OTS) is a complex biopsychosocial condition arising from a chronic imbalance between training load and recovery. OTS produces numerous psychiatric symptoms that remain systematically underrecognized in clinical practice. This review examines the neurobiological mechanisms linking OTS to mental health disorders, characterizes its psychiatric symptomatology, clarifies differential diagnosis with primary psychiatric conditions, and synthesizes current evidence on monitoring, prevention, and management. OTS affects numerous elite athletes during their careers, with a relapse rate of 80–90% within three years of recovery. Its neurobiological mechanisms — HPA axis exhaustion, serotonergic receptor dysregulation, neuroinflammatory activation, and autonomic nervous system dysfunction — overlap substantially with those of major depressive disorder, providing a mechanistic basis for the extensive psychiatric comorbidity observed clinically. OTS presents across three dimensions: affective and anxiety symptoms, neurocognitive and somatic impairment, and burnout. Differential diagnosis requires systematic exclusion of primary psychiatric disorders, Relative Energy Deficiency in Sport (RED-S), and organic pathology. Prevention and management form a continuum encompassing psychological monitoring, primary prevention strategies, and — in established OTS — multidisciplinary treatment including psychiatric and psychological interventions. OTS is a biopsychosocial condition whose psychiatric dimension is clinically substantial yet underdiagnosed. Its neurobiological overlap with major depressive disorder warrants integration of psychiatric expertise into the routine evaluation and management of overtrained athletes. The field remains constrained by the absence of validated diagnostic criteria and evidence-based psychological interventions — gaps that sports psychiatry is well-positioned to address.

  • Open Access

    GLP-1 RECEPTOR AGONISTS AND ALCOHOL USE DISORDER: PROMISE FOR A NEW TREATMENT APPROACH

    by Jakub Fidelus, Klaudia Jurkowska, Dominika Dutkiewicz, Julia Mądrzak, Olga Endler, Mikołaj Dybicz, Marianna Ciastoń, Magdalena Filuk, Julia Czerniewska, Marta Handzel

    The role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) as effective glucose-lowering and nephroprotective agents in type 2 diabetes is well established. Their emergence as treatments for obesity is considerably more recent. In the short time since this indication was approved, these medications have attracted considerable attention, and their use in clinical practise has expanded rapidly. Amid this rapid expansion, clinicians have encountered growing anecdotal reports from patients taking GLP-1RAs describing unexpected improvements in substance use behaviours. Such reports are consistent with a growing body of preclinical evidence demonstrating that GLP-1RAs reduce intake of alcohol and other addictive substances. Whether preclinical observations can be replicated in human studies is currently being tested in clinical trials. One prevailing hypothesis suggests that glucagon-like peptide-1 (GLP-1) exerts its effects via central mechanisms, including, at least in part, modulation of dopamine transmission. Studies imply that activation of central glucagon-like peptide -1 receptors (GLP-1Rs) functionally regulates the mesolimbic reward pathway and reduces addiction-like behaviors in rodent models. This narrative review summarizes the existing evidence regarding the effects of GLP-1RAs on alcohol consumption. Relevant studies published between January 2015 and March 2026 were identified via literature search. Collectively, the evidence supporting GLP-1RAs for the treatment of AUD is promising yet inconsistent, with randomized clinical trials yielding mixed results for the primary outcome of reduced alcohol consumption. Although current findings do not justify changes to clinical practice, they point toward potential benefits of GLP-1RAs, extending beyond glycemic and weight control, particularly among patients with AUD.

  • Open Access

    SEMAGLUTIDE FOR WEIGHT REDUCTION: A COMPARATIVE ANALYSIS WITH OTHER PHARMACOLOGICAL TREATMENTS

    by Marta Handzel, Julia Czerniewska, Klaudia Jurkowska, Julia Mądrzak, Olga Endler, Mikołaj Dybicz, Marianna Ciastoń, Magdalena Filuk, Jakub Fidelus, Dominika Dutkiewicz

    Obesity is a chronic, complex disease linked to major illness and death. Related conditions include heart disease, type 2 diabetes, and cancer. Its global prevalence has soared, demonstrating the need for treatments beyond lifestyle change. Pharmacotherapy is essential, particularly for people unable to maintain weight loss through behavioural interventions. This review evaluates the efficacy and safety of glucagon-like peptide-1 (GLP-1) receptor agonists, specifically semaglutide and liraglutide. These are assessed against established anti-obesity drugs, including orlistat and phentermine. A structured search was carried out across PubMed, Scopus, and Google Scholar. Priority was given to randomised controlled trials, meta-analyses, and large observational studies published from 2010 to 2025. Key clinical trial programmes, such as STEP, SUSTAIN, LEADER, SELECT, and SURMOUNT, were critically reviewed. Semaglutide shows superior efficacy. Mean weight reductions often exceed 10–15%. These reductions are linked to considerable improvements in glycaemic and cardiometabolic parameters. Liraglutide provides modest weight loss but has proven cardiovascular benefits. Orlistat and phentermine have lower efficacy. They also have tolerability issues and limited long-term use. Despite their strengths, GLP-1 receptor agonists cause gastrointestinal side effects, high cost, and have limited long-term safety data. GLP-1 receptor agonists represent a major advance, making obesity treatment more targeted. Future studies ought to focus on long-term outcomes, accessibility, and improving the tolerability and affordability of therapy.